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Abstract Extracts (34) from eight plant species of the
Peruvian Amazonia currently used in traditional Peruvian
medicine, mostly as antileishmanial remedies and also as
painkiller, antiseptic, antipyretic, anti-inflamatory, antiflu,
astringent, diuretic, antipoison, anticancerous, antiparasitic,
insecticidal, or healing agents, have been tested for their
antileishmanial, antitrypanosomal, and cytotoxic activity.
Plant species were selected based on interviews conducted
with residents of rural areas. The different plant parts were
dried, powdered, and extracted by maceration with different
solvents (hexane, chloroform, and 70% ethanol–water).
These extracts were tested on promastigote forms of
Leishmania infantum strain PB75, epimastigote forms of
Trypanosoma cruzi strain Y, and the mammalian CHO cell
line. Parasite viability and nonspecific cytotoxicity were
analyzed by a modified MTT colorimetric assay method.
The isolation and identification of pure compounds from
selected extracts were performed by column chromatogra-
phy, gas chromatography mass spectrometry (GC-MS;
mixtures), spectroscopic techniques [MS, infrared (IR),
ultraviolet (UV)], and mono and two-dimensional 1H and
13C nuclear magnetic resonance (NMR; COSY, HSQC,
NOESY) experiments. Chondodendron tomentosum bark
and Cedrela odorata were the most active extracts against
Leishmania, while C. odorata and Aristoloquia pilosa were
the most active against Trypanosoma, followed by Tabe-
buia serratifolia, Tradescantia zebrina, and Zamia ulei. Six
compounds and two mixtures were isolated from Z. ulei
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[cycasin (1)], T. serratifolia {mixtures 1–2, and naphtho-
quinones 2-acetyl-4H,9H-naphtho[2,3-b]furan-4,9-dione
(2) and 2-(1-hydroxyethyl)-4H,9H-naphtho[2,3-b]furan-
4,9-dione (3)}, and C. tomentosum [chondrocurine (4); (S,
S′)-12-O-methyl(+)-curine (5); and cycleanine (6)]. Four
compounds and the two mixtures exhibited significant
activity.
Introduction
The Peruvian Amazonia is among the regions of the planet
with the greatest plant diversity. Many of these plants are
traditionally used in popular medicine (Kvist et al. 2006;
Mejia and Rengifo 2000; Perez and Iannacone 2006; Rojas
et al. 2003).
Phytotherapy has recently received considerable atten-
tion as an alternative to chemotherapy in parasitic disease
control. Trypanosoma cruzi is the aethiologic agent of
Chagas disease, a public health problem in many Latin
American countries. Additionally, the population emigra-
tion from South American countries to Europe has resulted
in the presence of Chagas disease in some European
countries (Gascon et al. 2010; Muñoz et al. 2007). The
current treatment of Chagas disease is a challenge since the
only available drugs, nifurtimox and benznidazole, have
severe side effects, and problems are encountered in their
production and distribution (Muelas Serrano et al. 2000;
Sra et al. 2004).
Leishmaniasis is a protozoan parasitic disease endemic in
88 countries with a high associated morbidity and mortality
rate. The drugs most commonly used to treat leishmaniasis
are pentavalent antimonials, amphotericin B, paromomycin,
and pentamidine, which require high dosage over long
periods and are administered parenterally. In the case of
amphotericin B, toxicity and high cost are other limitations
(Passero et al. 2011). These drugs are far from satisfactory
due to their side effects at effective doses. Even miltefosine,
the newly introduced drug, has indicated potential resis-
tance against visceral leishmaniasis (Sánchez-Cañete et al.
2009).
In both cases, Chagas disease and leishmaniasis, the
search for new compounds to improve current treatments is
urgently needed (Correa et al. 2011; Croft et al. 2005;
Ghosh et al. 2011; Murray et al. 2005).
In this work, we have screened the in vitro activity of 34
extracts obtained from eight plant species from the Peruvian
rain forest against Leishmania infantum promastigotes and
T. cruzi epimastigotes as a first step in the search of new
natural active compounds. The cytotoxic effects on mam-
malian cells (CHO cell line) were tested in all cases. All the
plants studied are traditionally used in popular medicine,
some of them as leishmanicidal and antiparasitic agents
(Estevez et al. 2007; Kvist et al. 2006; Mackinnon et al.
1997; Mejia and Rengifo 2000; Perez and Iannacone 2006;
Rojas et al. 2003). Furthermore, the active compounds from
Chondodendron tomentosum, Tabebuia serratifolia, and
Zamia ulei have been isolated and characterized.
Material and methods
General experimental procedures
Gas chromatography mass spectrometry (GC-MS) analysis
was performed using a Hewlett-Packard HP 5890A gas
chromatograph coupled to a Hewlett-Packard HP 5971A mass
detector in the electron impact mode (70 eV) and equipped
with a capillary column. High performance liquid chromatog-
raphy (HPLC) was carried out in a Gilson apparatus with
ultraviolet (UV) detector and SP-4270 integrator. Optical
rotations were determined at room temperature using a
Perkin-Elmer 241 polarimeter. Nuclear magnetic resonance
(NMR) spectra were measured on a Bruker AMX-500
spectrometer with pulsed field gradient, using the solvent as
an internal standard (CDCl3, at δH 7.26 and δC 77.0). Mass
spectra and high resolution MS (HRMS) were taken at 70 eV
in a Micromass Autospec and electrospray ionization MS
(ESI-MS) were recorded in a LCT Premier XE Micromass
spectrometer. Silica gel from Merck (15111 and 5554) was
used for column chromatography and preparative thin-layer
chromatography (TLC). Silica gel G 1500/LS 254 (200×
200×0.25 mm plates), Schleicher & Schuell, Ref. 391132
plates were used for semipreparative TLC.
Plant material
The different plant species were selected according to
previous reports (Mejia and Rengifo 2000; Rojas et al.
2003) along with the information obtained from interviews
conducted with people living in rural areas outside of the
City of Iquitos (Table 1).
All plants were collected between July and August 2003
at the biological station Allpahuayo Mishana (Iquitos-Nauta
Road, San Juan Bautista District, Province of Maynas,
Department of Loreto), except for C. tomentosum, which
was collected at the Regional Research Centre CRI-IIAP-
Pucallpa also in July 2003. Harvested plants were identified
and classified in the Herbarium Amazonense of the
Universidad Nacional de la Amazonía Peruana, where
voucher samples are on deposit.
Preparation of extracts
The different plant parts were dried, powdered, and
extracted by maceration with different solvents (hexane,
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Table 1 Plants selected for in vitro investigation and parts of plants studied
Botanical name
and family
Voucher
number
Common
name
Plant part Extract Yield
(%)
Traditional applications
Aristolochia
pilosa L.
Aristolochiaceae 025860 Huancahui sacha Stem H 0.18 Snake bite
C 0.43
E-w 0.70
Leaf H 0.33
C 0.85
E-w 1.00
Brunfelsia
grandiflora L.
Solanaceae 026365 Chiric sanango Stem H 0.19 Leishmaniasis, reconstituent,
antirheumatic febrifuge, yellow
fever, antisyphilitic, diuretic
C 0.39
E-w 1.70
Leaf H 0.15
C 0.46
E-w 1.22
Cedrela odorata L.
Meliaceae 033574 Cedro amargo Bark H 0.37 Astringent, febrifuge, tonic
C 0.92
E-w 2.43
Chondodendron
tomentosum
Ruiz & Pavón
Menispermaceae 033896 Curare Bark H 0.53 Antiseptic, anti-inflamatory, rheumatism,
jaundice, dropsy, gonorrhoea, anaestheticC –
E-w 1.42
Leaf H 0.90
C –
E-w 3.73
Bark & leaf A 0.26
Paullinia clavigera
Schltdl
Sapindaceae 033368 Sacha yoko Bark H 0.16 Insecticide
C 0.75
E-w –
Tabebuia
serratifolia (Bahl)
G. Nicholson
Bignoniaceae 034665 Tahuarí Bark H 0.49 Bronchitis, flu, gallstones, anticancerous,
diabetes, fever, leishmaniasis, rheumatismC 1.16
E-w 1.45
Tradescantia zebrina
(Rose) D.R. Hunt
Commeliaceae 011382 Oreja de tigre Aerial part H 1.36 Insecticidal
C 2.27
E-w 2.57
Zamia ulei Dammer
Zamiaceae 027675 Lengua de perro Underground
tuberous stem
H – Leishmaniasis, healing
C –
E-w 2.24
H Hexane, C chloroform, E-w Hydroalcoholic extract, A alkaloid extract
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chloroform, and 70% ethanol–water) for 48–72 h at room
temperature. The extracts were filtered and concentrated in
vacuo (Table 1). A mixture of CH2Cl2 and 0.5 M H2SO4
(1:1) was added to the ethanolic extract and stirred for 12 h
to prepare the alkaloidal extract from C. tomentosum. The
aqueous phase was filtered, its pH increased to 9 with
NH4OH and repeatedly extracted with CH2Cl2. The
evaporation of the solvent gave a crude alkaloidal extract.
Fractionation and isolation of pure compounds
The dry ground rhizome of Z. ulei (300 g) was extracted by
maceration with ethanol for 48–72 h at room temperature to
give 23.1 g of extract (7.7% yield). The extract was
chromatographed on a vacuum liquid chromatograph
(VLC) column and eluted with an n-Hex: EtOAc gradient
of increasing polarity to give seven fractions. Further
purification of the active fractions 6 and 7 by CC and/or
HPLC (λ 250 nm; flow rate 3 ml/min, Ultrasphere Si
column 10×250 mm, 5 μm particle size) eluted with
mixtures of n-Hex:EtOAct of increasing polarity resulted in
the isolation of cycasin (1) (40.6 mg, 13.5×10−3%).
Cycasin (1) ESI-MS: m/z 275.0855 [M+Na]+; calculated
for C8H16N2O7Na;
1H RMN (500 MHz, CDCl3): δH 4.06
(3H, br t, J=1.5 Hz,=NO–CH3), 5.05 and 5.15 (1 H each,
dq, J=14.4 and 1.6 Hz, O–CH2–N), 4.52 (1H, d, J=
12.8 Hz, H-1, anomeric proton), 3.84 and 3.64 (1H, each,
dd, J=2.2, 12.0 and J=5.5, 12.0 Hz, respectively, CH2OH),
3.20 and 3.40 (4H, m geminal to the hydroxyl proton of the
glycoside). 13C RMN (500 MHz, CDCl3): δC 55.6 (q, NO–
CH3), 81.2 (t, C-7), 101.1 (d, C-1), 61.2 (t, C-6), 76.7 (d, C-
2), 76.5 (d, C-3), 73.5 (d, C-4), 70.1 (d, C-5).
T. serratifolia bark (650 g) was extracted by maceration
with ethanol for 48–72 h at room temperature to give 53.6 g
of extract (8.25%). This extract was fractionated on a VLC
column eluted with an AcOEt:MeOH gradient of increasing
polarity to give ten fractions. Further purification of the
active fractions 4, 6, and 10 by HLPC (λ 250 nm; flow rate
3 ml/min, Ultrasphere Si column 10×250 mm, 5 μm particle
size) eluted with mixtures of n-Hex:EtOAct of increasing
polarity to give two compounds [2-acetylnaphtho[2,3-b]
furan-4,9-dione (2) (2.5 mg, 3.8×10−4%), 2-(1-hydrox-
yethyl)-naphtho[2,3-b]furan-4,9-dione (3) (7.9 mg, 1.22×
10−3%)] and two mixtures [mixture 1 (26.2 mg, 4.03×
10−3%) and mixture 2 (5.9 mg, 0.9×10−3%)].
2-Acetyl-4H,9H-naphtho[2,3-b]furan-4,9-dione (2) EIMS:
m/z (rel. int.,%): [M]+ 240 (62), 225 (100), 197 (2). 173
(2). 157 (8), 141 (3), 129 (4), 113 (12), 76(6) y 57 (12). 1H
NMR (500 MHZ, CDCl3): δH 2.60 (3H, s, H-11), 7.5 (1H, s,
H-3), 7.75 (2H, m, H-6 y H-7), 8.18 (2H, m, H-5 y H-8). 13C
NMR (400 MHZ, CDCl3): δC 187.9 (s, C-10), 180.2 (s, C-4),
174.4 (s, C-9), 155.8 (s, C-9a), 153.2 (s, C-3a), 137.4 (s, C-
2), 134.8 (d, C-6 and C-7), 134.7 (s, C-8a), 131.1 (s, C-4a),
127.6 (d, C-5 and C-8), 112.8 (d, C-3), 27.0 (q, C-11).
2-(1-Hydroxyethyl)-4H,9H-naphtho[2,3-b]furan-4,9-dione
(3) EIMS: m/z (rel. int.,%): [M]+ 242 (44), 227 (100), 200
(48), 199 (39), 171 (20), 115 (24), 113 (7), 105 (24), 104
(11). HREIMS: m/z 242.0575 [M]+; calculated for C14 H10
O4;
1H NMR (500 MHz, CDCl3): δH 1.61 (3H, d, J=
6.7 Hz, H-11), 5.03 (1H, q, J=6.7 Hz, H-10), 6.84 (1H, s,
H-3), 7.74 (2H, m, aromatic protons), 8.19 (2H, m,
aromatic protons). 13C NMR (400 MHZ, CDCl3): δC
180.7 (s, C-4), 173.5 (s, C-9), 165.1 (s, C-2), 151.9 (s, C-
9a), 151.0 (s, C-3a), 133.9 (d, C-6), 133.8 (d, C-7), 133.0
(s, C-8a), 132.5 (s, C-4a), 127.0 (d, C-5), 126.9 (d, C-8),
103.7 (d, C-3), 63.8 (d, C-10), 21.7 (q, C-11).
Mixtures 1–2 were analyzed by GC-MS. Working
conditions were as follows: injector and transfer line
temperature was 280°C. A capillary column (HP-1,
30 m×0.25 mm i.d.×0.25 μm d.f.) was temperature-
programmed from 70 to 270°C, 4°C min−1. Electron-
induced mass spectra (EIMS) and retention data were used
to assess the identity of compounds by comparing them
with those of standards or those found in the Wiley MS
library. Quantitative data were obtained directly from the
TIC peak areas.
The dry bark of C. tomentosum (700 g) was extracted by
maceration with ethanol for 48–72 h at room temperature to
give 54.6 g of extract (7.8% yield). The extract was
fractionated on a Sephadex column eluted in n-hex:
CH2Cl2:MeOH 1:1:1, to give three fractions. The alkaloids
from fraction 1 were extracted as described (Reina et al.
2001) to give a crude alkaloidal extract (1.8 g, 0.25%). This
extract was purified by CC to give the alkaloids chondro-
curine (4) (3.4 mg, 4.8×10−4%); 12-O-methyl-(+)-curine
(5) (15.4 mg, 2.2×10−3%), and cycleanine (6) (5.3 mg,
7.5×10−4%).
Chondrocurine (4) [α]D=+130 (c, 6×10
−2, CHCl3). EIMS:
m/z (rel. int.,%): [M]+ 594 (28), 442 (10), 398 (7), 369 (4),
341 (2), 299 (22), 298 (100), 297 (23), 296 (17), 266 (7),
253 (15), 208 (23), 180 (23), 180 (43), 160 (23), 136 (33),
134 (18), 91 (14), 83 (10), 81 (12), 57 (50). HREIMS: m/z
594.2733 [M]+; calculated for C36H38N2O6.
1H NMR
(500 MHz, CDCl3): δH 6.57 (1H, s, H-5′), 5.87 (1H, H-
8′), 6.74 (1H, s, H-5), 6.27 (1H, d, J=2.0 Hz, H-10′), 6.83
(1H, dd, J=8.4, 2.2 Hz, H-14), 7.06 (1H, dd, J=8.4, 2.2 Hz,
H-14′), 6.79 (1H, dd, J=8.0, 2.0 Hz, H-13′), 6.70 (1H, dd,
J=8.0, 2.4 Hz, H-13), 6.54 (1H, dd, J=8.0, 2.0 Hz, H-10),
3.92 (1H, d, J=8.5 Hz, H-1′), 3.83 (3H, s, OMe), 3.78 (3 H,
s, OMe), 2.42 (3H, s, N-Me), 2.18 (3H, s, N-Me), 3.80 (1H,
m, H-1), 3.10 and 3.30 (4H, m, H-3 y H-3′), 2.66 and 2.79
(4H, m, H-4, H-4′). 13C NMR (400 MHz, CDCl3): δC 155.4
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(s, C-12′), 148.0 (s, C-6′), 146.7 (s, C-6), 145.9 (s, C-12),
143.1 (s, C-11), 143.1 (s, C-7′), 137.9 (s, C-8), 137.2 (s, C-
7), 132.6 (s, C-9), 132.2 (d, C-10′), 131.7 (s, C-9′), 129.9
(d, C-14′), 128.6 (s, C-4a′), 128.1 (s, C-8a′), 125.7 (d, C-
14), 125.4 (s, C-8a), 124.6 (s, C-4a), 121.0 (d, C-10), 117.9
(d, C-8′), 115.4 (d, C-13), 114.9 (d, C-13′), 111.9 (d, C-5′),
107.7 (d, C-5), 64.4 (d, C-1′), 59.3 (d, C-1), 56.0 and 55.8
(s, 2×OMe), 46.5 (t, C-3′), 44.2 (t, C-3), 42.5 and 42.4 (q,
2×N-Me), 25.2 (t, C-4′), 23.2 (t, C-4).
(S,S′)-12-O-methyl(+)-curine (5) [α]D=+ 128.7 (c, 0.282,
CHCl3). EIMS: m/z (rel. int.,%): [M]
+ 608 (23), 607 (17),
593 (9), 313 (7), 312 (31), 31 (3), 298 (19), 297 (8), 296
(18), 190 (13), 86 (81), 84 (100). HREIMS: m/z 608.2884
[M]+; calculated for C37H40O6N2;
1H NMR (500 MHz,
CDCl3). δH 2.21 (3H, s, N-Me), 2.57 (3H, s, N-Me), 2.43–
2.94 (3H, m, H-4 and H-4′), 3.20 (1H, br d, J=9.9 Hz, H-
α), 2.8 (1H, m, H-α′), 3.36 and 2.75 (1H each, m, H-3 and
H-3′), 3.60 (1H, m, H-1), 3.79 and 2.88 (3H each, s, OMe),
3.92 (1H, m, H-1′), 3.95 (3H, s, OMe), 5.82 (1H, s, H-8′),
6.26 (1H, d, J=2.0 Hz, H-10), 6.51 (1H, s, H-5), 6.60 (1H,
br d, J=8.4 Hz, H-14′), 6.62 (1H, s, H-5′), 6.68 (1H, d, J=
8.4, 2.4 Hz, H-13′), 6.75 (1H, d, J=8.0 Hz, H-13), 6.78
(1H, br dd, J=8.5 and 2.4 Hz, H-11), 6.82 (1H, br d, J=
8.1 Hz, H-14), 7.05 (1H, br d, J=8.4 Hz, H-10′). 13C RMN
(400 MHz, CDCl3): δC 155.5 (s, C-12′), 149.2 (s, C-6′),
148.7 (s, C-7′), 146.7 (s, C-6), 145.4 (s, C-12), 144.1 (s, C-
11), 138.2 (s, C-8), 137.5 (s, C-7), 133.7 (s, C-9), 132.6 (s,
C-9′), 132.5 (d, C-14′), 131.0 (d, C-10′), 128.8 (s, C-4′a),
128.4 (s, C-8′a), 125.7 (d, C-14), 125.3 (s, C-4a), 125.2 (s,
C-8a), 120.1 (d, C-10), 117.9 (d, C-8′), 114.8 (d, C-11′),
114.2 (d, C-13′), 112.7 (d, C-13), 112.7 (d, C-5′), 108.3 (d,
C-5), 64.9 (d, C-1), 58.7 (d, C-1′), 56.5 (q, OMe), 56.4 (q,
2×OMe), 48.5 and 44.7 (t each, C-3 and C-3′, respective-
ly), 42.8 and 43.4 (q each, N-Me), 38.2 and 39.7 (t each, C-
α and C-α′, respectively), 26.7 (t, C-4′), 23.4 (t, C-4).
Cycleanine (6) EIMS: [M]+ m/z (rel. int.,%) 622 (63%),
313 (19), 312 (100), 311 (29), 204 (27), 190 (15), 174 (15),
159 (11), 146 (8), 145 (11). HREIMS: m/z 622.3071 [M]+;
calculated for C38H42N2O6.
1H NMR: (500 MHz, CDCl3)
δH 2.53 (s, 6 H, 2×N-Me), 2.51 (m, H-α), 3.25 (m, H-α′),
3.40 (s, 3H, OMe), 3.81 (s, 3H, OMe), 4.30 (2 H, d, J=
10.3 Hz, H-1 and H-1′), 2.92 and 3.29 (2 H, m, H-3 and H-
3′), 3.01 and 2.92 (2H, m, H-4 and H-4′), 6.57 (s, 2H, H-5
and H-5′), 7.82 (dd, 2H, J=8.4, 2.8 Hz, H-13 and H-13′),
6.60 (dd, 2H, J=8.4 and 2.8 Hz, H-11 and H-11′), 6.28 (dd,
2H, J=8.4 and 2.8 Hz, H-14 and H-14′), 7.06 (dd, 2H, J=
8.5, 2.1 Hz, H-10 and H-10′); 13C NMR (400 MHz, CDCl3)
δC 154.2 (s, C-12 and C-12′), 152.1 (s, C-6 and C-6′), 143.8
(s, C-18 and C-18′), 139.1 (s, C-7 and C7′), 130.3 (s, C-9
and C-9′), 129.5 (s, C-4a and C-4′a), 128.7 (d, C-14 and C-
14′), 128.3 (d, C-10 and C- 10′), 124.7 (s, C-8a and C-8′a),
117.5 (d, C-11 and C-11′), 114.0 (d, C-13 and C-13′), 109.2
(d, C-5 and C-5′), 60.1 (q, C-7 and C-7′), 59.6 (d, C-1 and
C-1′), 56.0 (q, C-6 and C-6′), 44.6 (t, C-3 and C-3′), 42.3
(q, 2×NMe), 37.9 (t, C-α and C-α′), 24.6 (t, C-4 and C-4′).
These data coincide with previous results (Scheinmann et
al. 1980).
Antileishmanial screening
Leishmanicidal activity was assayed on promastigote
forms of L. infantum PB75 strain, cultured at 28°C in
Roswell Park Memorial Institute (RPMI) medium supple-
mented with 10% fetal calf serum. Parasites in logarithmic
growth phase from an initial culture with 1×106 promas-
tigotes/ml were distributed in 96-well flat-bottom plates.
Each well was filled with 90 μl of culture after 2 days of
incubation. Extracts and compounds were tested at several
concentrations (extracts at 800, 400, and 100 μg/ml;
compounds at 100, 10, and 1 μg/ml) for 48 h. Amphoter-
icin B was used as reference drug and parasite viability
was analyzed by modified MTT colorimetric assay
(González-Coloma et al. 2002). Briefly, after 48 h, 10 μl
MTT/PMS were added to each well. Incubate 75 min to
occur the reduction of MTT and 100 μl sodium dodecyl
sulfate (SDS) were added to dissolve formazan crystals
obtained as a result of the reduction of MTT. Once the
crystals have dissolved (15–30 min), the plate was read on
a spectrophotometer at 570 nm. The activity was calcu-
lated as % growth inhibition (%GI) as follows:
% GI ¼ 100 Ap  Ab
 
= Ac  Abð Þ  100
 
, Ap being the
absorbance of problem wells (treated), Ac the absorbance
of control wells (not treated), and Ab the absorbance of
blank wells (culture medium and vehicle only). When
compounds showed activity, intermediate doses were
assayed and GI50 values (concentration that inhibits 50%
the growth of the parasites) were determined from linear
regression analysis (STATGRAPHICS Plus, version 5.1).
All assays were carried out in triplicate.
Trypanocidal in vitro activity
This activity was assayed on epimastigote forms of T. cruzi
Y strain, cultured in LIT medium supplemented with 10%
fetal calf serum. Parasites in logarithmic growth phase from
an initial culture with 2×106 epimastigotes/ml were
distributed in 96-well flat-bottom plates. Each well was
filled with 90 μl of culture after 2 days of incubation.
Extracts and compounds were tested at several concen-
trations (extracts at 800, 400, and 100 μg/ml; compounds at
100, 10, and 1 μg/ml) for 72 h. Nifurtimox was used as the
reference drug, and parasite viability was analyzed by a
modified MTT colorimetric assay method as described
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above (González-Coloma et al. 2002; Muelas Serrano et al.
2000). The activity (%GI and GI50) was calculated as
described above for Leishmania. All assays were carried
out in triplicate.
Cytotoxicity assays
Mammalian Chinese hamster ovary (CHO) cells were used for
these assays. Cells were grown in RPMI medium supple-
mented with 10% L-glutamine, 10% fetal calf serum, and 1%
penicillin/streptomycin at 37°C under humidified atmospheric
conditions of 5% CO2/95% air. Cells were seeded in 96-well
flat-bottom microplates with 100 μl medium per well (initial
densities of 104 cells per well) and incubated under the same
conditions. After 24 h, the medium was removed and added
fresh medium containing the extracts or compounds. Cells
were exposed for 48 h to several concentrations of the
extracts and compounds (extracts at 800, 400, and 100 μg/ml;
compounds at 100, 10, and 1 μg/ml). The toxicity of
reference drugs (amphotericin B and nifurtimox) was also
evaluated. Cell viability was analyzed by the MTT colori-
metric assay method (Mossman 1983). After 48 h, 10 μl of a
solution of 5 mg/ml MTT in PBS was added to each well.
After 4 h, the supernatant was removed, and 100 μl DMSO
were added to each well. The plate is read on a spectropho-
tometer at 570 and 620 nm. The activity is expressed as the
proportion of viable CHO cells (percentage of viability) as
follows: % of viability ¼ Ap  Ab
 
= Ac  Abð Þ  100, where Ap
is the absorbance of problem wells (treated), Ac is the
absorbance of control wells (not treated), and Ab is the
absorbance of blank wells (culture medium and vehicle only).
When compounds showed activity, intermediate doses were
assayed and GI50 values (concentration that inhibits 50% the
growth of the cells) were determined from linear regression
analysis (STATGRAPHICS Plus, version 5.1). All assays
were carried out in triplicate.
Results and discussion
Effects of the plant extracts
The antileishmanial and antitrypanosomal activity of 34
extracts (hexane, chloroform, and 70% EtOH) obtained
from eight Peruvian plant species is reported in Table 2. We
also obtained an alkaloidal extract from the aerial parts of
C. tomentosum (bark and leaves). Overall, the hexane and
chloroform extracts from Cedrela odorata, the alkaloid
extract from C. tomentosum and the chloroform extract
from T. serratifolia proved to be the most active against
both parasites. Hexane extracts from Tradescantia zebrina
and chloroform extract from Z. ulei showed selective
activity against T. cruzi epimastigotes (at 100 μg/ml). The
chloroform and hydroalcoholic extracts from C. tomentosum,
and the chloroform extract from Paullinia clavigera
exhibited selective activity against L. infantum promastigotes
(at 100 μg/ml). We can conclude that C. tomentosum bark
and C. odorata are the most effective extracts against
Leishmania, followed by C. tomentosum leaves, T. serrati-
folia, and Aristoloquia pilosa. On the other side, C. odorata,
A. pilosa, and alkaloid extract of C. tomentosum proved to be
most effective against Trypanosoma, followed by T. serra-
tifolia, T. zebrina, and Z. ulei.
Table 3 shows the nonspecific cytotoxicity of the
extracts tested at the concentrations showing antiparasitic
effects. While most of the extracts studied were cytotoxic,
the chloroform extract from C. odorata bark, the hydro-
alcoholic extract from C. tomentosum bark, the chloroform
extract from P. clavigera bark, and the hexane extract from
leaves of Brunfelsia grandiflora were not.
T. serratifolia, Z. ulei, and B. grandiflora are used in
traditional medicine to treat ulcers and wounds caused by
leishmaniasis. These plants are applied topically, using
macerated leaves or resin or latex (Kvist et al. 2006; Mejia
and Rengifo 2000). Our results confirm the presence of
compounds with leishmanicidal activity in these plants. The
extracts from the bark of T. serratifolia and the extracts
from stem and leaf of B. grandiflora exhibited similar
activity against both parasites. In the case of B. grandiflora,
the stem and the root are the most commonly used plant
parts for the treatment of parasitic diseases (Mejia and
Rengifo 2000). However, our results showed that the leaves
also exhibit antiparasitic activity. C. odorata and other
plants of the Meliaceae family have been used in traditional
medicine for the treatments of fevers, a characteristic
symptom of malaria. Extracts from this plant and genudin
derivatives have been previously assayed against Plasmo-
dium with interesting results (Mackinnon et al. 1997).
However, this is the first report on its activity against
Leishmania or Trypanosoma. It is interesting to note the
strong antiparasitic effects of the alkaloidal extract of C.
tomentosum. Alkaloid extracts from Menispermaceae
exhibited antimalarial activity and in vitro toxicity against
the tumoral cell lines KB-3, KB-V1 and P-38878 (Lin et al.
1993). Additionally, we found interesting leishmanicidal
activity for P. clavigera or A. pilosa extracts.
Identification and effects of mixtures and isolated
compounds
Two of the four most active plants against both of the
parasites (C. tomentosum and T. serratifolia), and a plant
with selective action against one of them (Z. ulei) were
subjected to bioassay-guided fractionation.
The phytochemical study of the active fractions of the
underground tuberous stem of Z. ulei resulted in the
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Table 2 In vitro activity of hexane (H), chlorophorm (C), hydroalcoholic (E-w), and alkaloid (A) plant extracts against Leishmania infantum and
Trypanosoma cruzi
Plant species and part Extract % Growth inhibition
L. infantum T. cruzi
800 μg/ml 400 μg/ml 100 μg/ml 800 μg/ml 400 μg/ml 100 μg/ml
Aristoloquia pilosa
Stem H 99.1±0.6 99.0±0.7 37.8±9.9 100.0±0.0 99.0±0.9 59.1±7.8
C 95.6±0.1 89.8±0.4 73.3±2.2 98.2±0.5 95.4±0.4 88.4±1.2
E-w 0.0 0.0 0.0 15.1±3.6 0.0 0.0
Leaf H 99.9±0.2 98.5±0.2 40.8±5.5 100.0±0.5 99.0±0.4 42.4±1.7
C 92.2±0.7 84.1±0.7 60.3±1.0 91.0±0.8 86.0±0.5 76.5±1.2
E-w 22.0±4.0 0.0 0.0 36.7±8.2 20.4±2.9 0.0
Brunfelsia grandiflora
Stem H 99.0±0.6 54.6±2.7 0.0 22.0±9.0 0.0 0.0
C 88.0±3.2 13.0±1.6 12.0±1.2 98.0±1.3 95.0±2.3 27.2±2.0
E-w 77.2±7.3 8.5±1.8 3.0±4.2 72.6±2.1 46.6±1.6 4.2±3.7
Leaf H 98.1±0.1 97.4±1.3 47.9±7.1 82.0±1.0 51.5±2.1 0.0
C 69.2±0.9 38.8±13.8 3.1±3.2 97.7±0.6 93.5±0.2 33.2±2.7
E-w 42.5±5.8 8.4±6.2 5.0±4.5 46.0±8.7 42.0±4.8 16.1±1.8
Cedrela odorata
Bark H 98.1±0.3 97.3±0.6 95.9±0.5 100.0±0.4 100.0±0.2 100.0±0.5
C 100.0±1.8 100.0±0.2 100.0±0.1 97.9±0.4 95.1±1.1 76.5±1.2
E-w 0.0 0.0 0.0 72.1±0.7 50.9±2.3 0.0
Chondodendron tomentosum
Bark H 15.0±9.9 0.0 0.0 96.5±0.9 21.7±5.6 0.0
C 93.0±1.0 93.0±0.4 93.0±1.0 100.0±0.5 89.9±2.2 28.0±1.2
E-w 100.0±1.1 97.0±0.4 91.0±1.2 42.1±2.6 24.0±2.2 0.0
Leaf H 99.0±0.1 96.0±0.7 19.68±2.9 97.2±0.2 27.3±5.8 0.0
C 85.6±10.6 80.5±4.8 44.0±6.9 32.8±7.7 14.5±5.9 0.0
E-w 89.0±3.1 87.0±2.0 84.0±1.0 27.9±0.6 4.0±5.1 0.0
Bark & leaf A 100.0±4.2 100.0±2.2 100±0.0a 82.9±4.0 90.9±0.7 96.5±0.5a
Paullinia clavigera
Bark H 93.9±1.5 92.1±0.9 20.1±3.4 56.0±2.2 47.2±3.0 5.7±5.2
C 100.0±0.8 100.0±2.7 74.1±5.6 100.0±0.2 89.9±1.0 38.4±3.6
E-w 0.0 0.0 0.0 0.0 0.0 0.0
Tabebuia serratifolia
Bark H 100.0±0.5 99.1±0.7 37.8±9.9 100.0±0.2 99.5±0.5 24.8±4.0
C 100.0±0.4 98.9±2.8 90.5±0.7 98.0±1.3 96.0±1.0 94.0±0.7
E-w 1.5±3.2 0.0 0.0 47.6±1.8 28.5±3.7 14.3±1.6
Tradescantia zebrina
Aerial part H 96.4±1.2 93.5±0.4 7.8±1.4 96.0±1.4 95.0±1.0 73.5±3.2
C 23.8±3.2 6.3±2.0 4.1±2.7 27.0±11.6 0.0 0.0
E-w 0.0 0.0 0.0 35.7±7.1 17.4±7.4 13.4±4.4
Zamia ulei
Underground tuberous stem H 84.7±1.0 72.2±1.3 27.5±3.5 78.2±2.0 77.0±0.6 28.2±6.2
C 93.3±1.2 84.2±1.3 0.0 92.5±2.3 88.2±0.2 62.9±1.0
E-w 0.0 0.0 0.0 26.4±5.7 10.1±1.4 7.8±3.3
a Concentration assayed: 200 μg/ml
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isolation of cycasin (1) (Fig. 1). Cycasin (1) has previously
been isolated from other species such as Cycas revoluta
(Nishida et al. 1955, 1956), Bowenia spectabilis, Stangeria
eriopus, Ceratozamia mexicana, Lepidozamia hopei, Ence-
phalartos villosus, Macrozamia miquelii, and Zamia
fischeri (Yagi 2004).
Mixtures 1 and 2 were isolated from T. serratifolia, and
they were identified using GC-MS. Their composition is
shown in Table 4. Mixture 1 is composed of saturated
alkanes and the isoflavonoid rotenalone which is the major
component (15.1%), followed by triacontane (6.2%),
hentriacontane (6.0%), and an unknown compound of
[M]+ 396 (6.0%). Rotenalone has been reported as
cytotoxic against the A 2,780 human ovarian cancer cell
line (Cao et al. 2004). The major components of mixture 2
were two unidentified compounds of [M]+ 422 (6.7%) and
[M]+ 396 (6.9%). Among the compounds present in
mixture 2, eicosane, octacosane, and octadecane are present
in essential oils and extracts of various plants, and their
activity on various bacteria, fungi, and viruses have been
reported (Zai-Chang et al. 2005; Kuiate et al. 2006;
Karabay et al. 2007; Mazutti et al. 2008).
Naphthoquinones 2 and 3 were also isolated from T.
serratifolia. They were identified using spectroscopic
techniques (MS, IR, UV) and mono and two-dimensional
1H and 13C NMR (COSY, HSQC, NOESY) experiments
(Fig. 1). Both were previously isolated from Tabebuia
cassinoides and T. ochracea (Zani et al. 1991).
The bisbenzylisoquinoline alkaloids (BBIQs) chondro-
curine (4), (S,S′)-12-O-methyl(+)-curine (5), and cycleanine
(6) were isolated from C. tomentosum. They were identified
by spectroscopic techniques (MS, IR, UV) and 1H NMR
Table 3 In vitro cytotoxicity
of hexane (H), chlorophorm (C),
hydroalcoholic (E-w), and alka-
loid (A) plant extracts on CHO
cells
The activity is expressed as the
proportion of viable CHO cells
(percentage of viability) after
48 h of contact with the extract.
Only the extracts and concen-
trations active on parasites were
assayed on CHO cells
aConcentration assayed: 200
μg/ml
Plant species and part Extract % of viability
800 μg/ml 400 μg/ml 100 μg/ml
Aristoloquia pilosa
Stem H 0.2±0.2 1.2±0.2 9.5±1.6
C 17.3±3.1 22.3±0.5 33.5±1.6
Leaf H 0.5±0.4 0.2±0.1 –
C 1.9±0.4 5.5±2.1 –
Brunfelsia grandiflora
Stem H 3.4±0.8 30.9±3.0 35.7±5.7
C 4.2±1.7 – –
E-w 0.4±0.2 – –
Leaf H 0.0 58.5±3.4 49.9±6.2
Cedrela odorata
Bark H 0.0 0.0 1.72±1.7
C 67.1±1.6 95.5±7.0 100.0±10.5
Chondodendron tomentosum
Bark H 0.7±0.4 1.8±1.2 –
C 1.9±0.9 1.4±0.7 2.6±1.5
E-w 48.6±17.0 87.9±13.23 66.0±11.1
Leaf C 0.0 0.0 –
E-w 12.7±1.9 4.3±1.8 14.5±1.6
Bark & leaf A 0.5±0.3 0.2±0.2 0.0a
Paullinia clavigera
Bark H 0.9±0.6 0.2±0.3 –
C 1.2±0.5 7.8±0.9 72.7±1.6
Tabebuia serratifolia
Bark H 0.0 1.8±0.9 –
C 0.0 0.0 –
Tradescantia zebrina
Aerial part H 0.0 27.9±2.5 –
Zamia ulei
Underground tuberous stem H 0.1±0.1 40.0±1.5 –
C 4.0±3.3 1.0±0.6 –
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and 13C mono and two-dimensional (COSY, HSQC,
NOESY) experiments (Fig. 2).
Chondrocurine (4) was first isolated from C. tomentosum
(Everette et al. 1970) and also found in other species of the
family. Compound 5 was first identified as (++)-4″-O-
methylcurine from Cissampelos pareira (Haynes et al.
1966). Cycleanine (6) is present in a wide range of
Menispermaceae and also in other families such as
Annonaceae (Leboeuf et al. 1982).
Table 5 shows the antiparasitic and cytotoxic effects of
the mixtures and pure compounds. Mixture 1 exhibited
moderate antileishmanial effects while mixture 2 showed
important activity against both parasites with higher
potency than nifurtimox and cytotoxicity values similar to
those of the reference drugs. Both naphthoquinones proved
to be quite active against both parasites (especially 3) with
GI50 values for T. cruzi lower than those of nifurtimox and
similar to amphotericin B for L. infantum. Although these
compounds are more toxic to CHO mammalian cells than
the reference drugs, it should be noted that compound 3 is
300× more active on epimastigote forms of T. cruzi than
nifurtimox.
Alkaloid 6 exhibited no significant activity, but 4 and 5
were active against both parasites (with lower potency than
the reference drugs). These compounds exhibited strong
activity against Leishmania but were less toxic to mammalian
CHO cells than the reference drugs. This variation in activity
may be due to the fact that 6 is composed of two coclaurine-
type isoquinoline units linked by two C8-C12′ and C8′–C12
head–tail ether bonds, while in 4 and 5, the units are linked
by C8–C12′ and C11–C7′ head–tail bonds. Previous studies
with compounds such as isotetrandrine, pheanthine, cepha-
O
R
O
O
3; R = OH
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HO
HOH2C
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H H
N N
CH3
1
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Fig. 1 Chemical structures of cycasin (1) and naphthoquinones 2 and 3
Table 4 Chemical composition
of mixtures 1–2 Compound Retention time Relative abundance (%)
Mixture 1 Tricosane 43.09 1.5
Tetracosane 45.22 3.1
Pentacosane 47.25 2.7
222[M]+ 47.43 1.4
Hexacosane 49.24 3.9
Heptacosane 51.13 3.7
Octacosane 52.97 3.0
Nonacosane 54.72 2.5
Triacontane 56.49 6.2
394[M]+ 56.88 1.0
Hentriacontane 57.86 6.0
396[M]+ 57.86 6.0
408[M]+ 62.67 2.7
Rotenalone 64.06 15.1
% Identified 58.8
Mixture 2 422[M]+ 45.28 6.7
Eicosane 49.27 1.5
Docosane 51.15 1.7
Octadecane 52.96 1.4
394[M]+ 57.50 5.4
396[M]+ 57.84 6.9
% Identified 23.6
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ranthine and cycleanine highlight the important role played
by stereochemistry in their activity (Thornber 1970).
In our study, cycasin (1) was not active. This compound
is a toxic azoxyglycoside whose main metabolite, methyl-
azoxymethanol (MAM), is responsible for insect toxicity
and genetic alterations in different systems (bacteria, yeasts,
plants, mammalian cells, etc.; Schneider et al. 2002; Yagi
2004). Therefore, the lack of activity of 1 may be due to its
low bioavailability to the parasites and/or cells due to its
high polarity, resulting in low amounts of released MAM
(responsible for the toxicity).
The naphthoquinones, lapachol, and lapachone, found in
the genus Tabebuia, proved active against Schistosoma
mansoni and T. cruzi (Do Campo et al. 1977, 1978).
Lapachol showed significant leishmanicidal activity in vitro,
high activity against T. cruzi and also interferes with oxygen
metabolism of tumor cells by blocking celular respiration
and the generation of oxygen free radicals (Hussain et al.
2007). Other naphthoquinones act by inducing oxidative
stress, reducing the consumption of oxygen in the respiratory
chain, and inhibiting electron transport (Colman de Saizarbi-
toria et al. 1997). It has also been reported that the activity of
naphthoquinones against sensitive and resistant strains of
Plasmodium falciparum to chloroquine may be due to the
presence of a methyl group which increases its lipophilicity
promoting drug accumulation in the mitochondria of the
parasite (Weiss et al. 2000). Naphthoquinones 2 and 3
exhibited significant activity against tumor cells KB (Rao
and Kingston 1982; Zani et al. 1991). In addition,
naphthoquinone 3 showed significant activity against Trypa-
nosoma brucei brucei, Trypanosoma brucei rhodesiense, P.
falciparum, and P. berghei (Weiss et al. 2000; Fournet and
Muñoz 2002) and against a wide range of microorganisms
(Kuete et al. 2007). Naphthoquinone 3 could have an
antiparasitic mode of action similar to that described for
other naphtoquinones, while the presence of a hydroxyethyl
group in its side chain could be responsible for an increase in
activity compared to 2. This is the first time that the activity
of these compounds against L. infantum and T. cruzi has
been described, although their activity has been reported for
other species of Trypanosoma.
BBIQ alkaloids proved to be active against T. cruzi and
P. falciparum, and some of them enhance the effect of
different antimalarial drugs and revert parasite resistance
(Lin et al. 1993). S,S′-12-O-methyl-curine (5) is present in a
root extract of Cissampelos mucronata with activity against
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Fig. 2 Chemical structures of chondrocurine (4), (S,S′)-12-O-methyl
(+)-curine (5) and cycleanine (6)
Table 5 In vitro activity on
Leishmania infantum,
Trypanosoma cruzi, and CHO
cells of mixtures 1–2 and
compounds 1–6
Results are expressed in GI50
(μg/ml). In brackets, confidence
limits 95%
Compound L. infantum T. cruzi CHO cells
Mixture 1 35.07 (18.99–64.76) >100 67.54 (48.11–94.82)
Mixture 2 2.49 (2.22–2.80) 1.57 (0.55–4.49) 11.02 (8.92–13.62)
1 >100 >100 59.54 (37.59–94.31)
2 2.15 (1.97–2.35) 2.36 (2.03–2.75) 5.39 (4.16–6.97)
3 0.19 (0.03–1.09) 0.01 (0.001–0.04) 2.72 (1.12–6.61)
4 0.85 (0.55–1.29) 21.69 (13.50–33.19) 45.48 (37.81–54.69)
5 0.76 (0.46–1.25) 22.83 (15.74–33.10) 41.69 (38.15–45.57)
6 52.96 (29.76–94.21) >100 51.41 (27.62–57.69)
Nifurtimox 3.39 (1.40–8.19) 13.91 (9.09–21.30)
Amphotericin B 0.04 (0.01–0.12) 10.25 (5.36–19.61)
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chloroquine-sensitive and chloroquine-resistant P. falci-
parun strains (W2 and D6) and showed moderate cytotox-
icity against KB cells (Tshibangu et al. 2003). Cycleanine
(6) showed activity against P. falciparum (chloroquine-
sensitive clone D6; Angerhofer et al. 1999), in vitro
antibacterial and strong fungicidal activity (Lohombo-
Ekomba et al. 2004), and in vitro activity against
Leishmania brasiliensis, Leishmania amazonensis, and
Leishmania donovani, but not to T. cruzi (Osorio et al.
2006). Furthermore, 6 showed strong activity in mice
infected with CL and Y strains of T. cruzi when
administered together with other alkaloids such as curine,
isotetrandine, limacine, and pheanthine (Fournet et al.
1997). Previous studies have reported that BBIQ alkaloids
act on the trypanothione reductase (a pathogen-specific
enzyme which is one of the main targets in the search for
new drugs against T. cruzi) similarly to other inhibitors of
this enzyme (nitrofurans and naphthoquinones), which have
a positive charge attached to a hydrophobic group. The
enzyme is inhibited when binding occurs, interfering with
catalysis of trypanothione disulfide reduction (the com-
pound responsible for oxygen exchange), the level of
oxygen in the parasite is reduced, and death occurs (Fournet
et al. 1998).
Conclusions
The results confirm the presence of leishmanicidal
activity for plants used for the treatment of ulcers (T.
serratifolia, Z. ulei, or B. grandiflora) and other uses (C.
tomentosum, C. odorata, P. clavigera, T. zebrine, or A.
pilosa). Some extracts also exhibited interesting trypano-
cidal activity. We also isolated the active compounds
responsible for the activity of C. tomentosum alkaloidal
extract and T. serratifolia chlorophorm extract. However,
the major compounds isolated from the active fractions of
Z. ulei were not active. One cause may be that the active
principle is present in a low proportion in the extract and
has not been isolated, or synergistic effects is existent in
the extract. To further check this, studies with combina-
tions of different compounds isolated from the extract
must be done.
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